Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Shock (Augusta, Ga.)|October 16, 2003
Sepsis and the dendritic cellPhilip Efron, Lyle L Moldawer
Expert Opinion on Therapeutic Targets|February 1, 2014
HMGB1 as a therapeutic target for sepsis: it's all in the timing!Lori F Gentile, Lyle L Moldawer
Future Microbiology|March 28, 2008
Using innate immunity to characterize the host response to microbial invasion in severe sepsisElizabeth A Warner, Lyle L Moldawer
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 28, 2006
The origins of cachexia in acute and chronic inflammatory diseasesMatthew J Delano, Lyle L Moldawer
The Journal of Burn Care & Rehabilitation|April 20, 2004
Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair responsePhilip A Efron, Lyle L Moldawer
The Proceedings of the Nutrition Society|September 18, 2004
Anti-cytokine and anti-inflammatory therapies for the treatment of severe sepsis: progress and pitfallsDouglas J Minnich, Lyle L Moldawer
Critical Care (London, England)|November 23, 2012
CXCR3 blockade: a novel anti-sepsis approach?Matthew J Delano, Lyle L Moldawer
Critical Care Medicine|February 13, 2002
Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drugAndreas Oberholzer, Caroline Oberholzer, Lyle L. Moldawer
Critical Care Medicine|January 10, 2002
Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drugAndreas Oberholzer, Caroline Oberholzer, Lyle L Moldawer
Critical Care Medicine|March 17, 2006
Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsisSven K Tschoeke, Andreas Oberholzer, Lyle L Moldawer
Pageof 27